Sociodemographic Disparities in Melanoma Stage at Diagnosis: The Role of Socioeconomic Status and Residential Location

BACKGROUND: Low tumor stage is associated with improved prognosis following diagnosis of primary melanoma. This study evaluated the associations between patient socioeconomic status (SES) and location of residence on tumor stage at melanoma diagnosis. METHODS: Patients with a new diagnosis of histologically confirmed melanoma of stages T1b to T4b in Queensland, Australia, were recruited between 2010 and 2014. Logistic regression models were used to assess whether SES or location of residence were associated with lower (T1b-T3a) versus higher (≥T3b) tumor stage. RESULTS: Of 700 study participants with melanoma, those living in lower SES areas (n = 358) had a higher likelihood of being diagnosed with ≥T3b-stage disease compared with patients in higher SES areas n = 342; adjusted OR = 1.65, 95% confidence interval (CI), 1.04-2.62; P = 0.03. Relative to patients living in urban areas (n = 389), patients living in inner regional areas (n = 209) were more likely to be diagnosed with a ≥T3b-stage melanoma (OR = 1.65; 95% CI, 1.11-2.46; P = 0.01); however, this finding was not significant following adjustment for SES (adjusted OR = 1.17; 95% CI, 0.72-1.91; P = 0.53). CONCLUSIONS: Patients residing in areas with lower average socioeconomic advantage were more frequently diagnosed with a locally advanced melanoma than patients in high-SES areas. Geographical remoteness was not independently associated with tumor stage at diagnosis in this cohort. IMPACT: Our study highlights a disparity in early melanoma detection across socioeconomic classes. Population groups who are disproportionately more likely to be diagnosed with a thicker primary melanoma should be considered for targeted screening initiatives and healthcare accessibility programs.